TRCT
CALC icon

Tower Research Capital (TRC)’s CalciMedica CALC Stock Holding History

Tower Research Capital (TRC)’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.09K Buy
+2,022
New +$4.1K ﹤0.01% 4725
2025
Q4 		– Sell
-666
Closed -$2.05K – 5187
2025
Q3 		$2.05K Sell
666
-2,327
-78% -$6.7K ﹤0.01% 4688
2025
Q2 		$4.79K Buy
2,993
+11
+0.4% +$19 ﹤0.01% 4267
2025
Q1 		$5.7K Buy
2,982
+1,758
+144% +$4.38K ﹤0.01% 4094
2024
Q4 		$6.12K Buy
+1,224
New +$4.29K ﹤0.01% 4204
2024
Q3 		– Sell
-921
Closed -$4.61K – 5724
2024
Q2 		$4.61K Sell
921
-1,260
-58% -$6.35K ﹤0.01% 4761
2024
Q1 		$10.9K Buy
2,181
+764
+54% +$3.49K ﹤0.01% 3630
2023
Q4 		$7.08K Buy
1,417
+1,226
+642% +$3.55K ﹤0.01% 4661
2023
Q3 		$955 Sell
191
-1,691
-90% -$5.61K ﹤0.01% 5445
2023
Q2 		$7.55K Buy
+1,882
New +$8.23K ﹤0.01% 4556
2022
Q2 		– Sell
-14
Closed – – 6093
2022
Q1 		$0 Sell
14
-158
-92% -$3.01K ﹤0.01% 6113
2021
Q4 		$4K Buy
172
+113
+192% +$4.39K ﹤0.01% 5282
2021
Q3 		$3K Sell
59
-877
-94% -$49.3K ﹤0.01% 5083
2021
Q2 		$71K Buy
936
+7
+0.8% +$459 ﹤0.01% 2719
2021
Q1 		$72K Buy
929
+877
+1,687% +$262K ﹤0.01% 2829
2020
Q4 		$21K Buy
+52
New +$15.3K ﹤0.01% 3831

Other funds holding CALC

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Tower Research Capital (TRC)'s CALC Position: Q1 2026 in Review

Tower Research Capital (TRC) opened a new position in CalciMedica (CALC) in Q1 2026: 2,022 shares worth $1.09K. The stake represents ﹤0.01% of the portfolio and ranks #4725 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in CALC as recently as Q3 2025.

Tower Research Capital (TRC) first reported a position in CALC in Q4 2020 and has held it in 16 quarters since. The position peaked at $72K in Q1 2021. 27 funds tracked by Wall St. Rank hold CALC as of Q1 2026.

  • Tower Research Capital (TRC) held 2,022 shares of CalciMedica worth $1.09K as of Q1 2026.
  • CalciMedica was a new Tower Research Capital (TRC) position in Q1 2026.
  • CalciMedica made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4725 holding.
  • Tower Research Capital (TRC) first reported a position in CalciMedica in Q4 2020 and has held it in 16 quarters since.
  • Tower Research Capital (TRC)'s CalciMedica position peaked at $72K in Q1 2021.
  • 27 funds tracked by Wall St. Rank held CalciMedica as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.